About

Tony J. Hunt has served on the 908 Devices board since March 2022. He was Executive Chairman of Repligen from September 2024 to March 2026 and previously its President and CEO from 2015, having joined as COO in 2014; before that he was President of Bioproduction at Life Technologies. He serves on the board of BioLife Solutions. He holds a B.S. in microbiology and an M.S. in biotechnology from University College Galway and an MBA from Boston University.

Roles

908 Devices Inc.
Director · Current role
March 2022–present
Repligen Corporation
Executive Chairman
September 2024 - March 2026
Repligen Corporation
President and Chief Executive Officer
May 2015 - 2024
Life Technologies
President of Bioproduction
2011 - 2014

External Roles

BioLife Solutions, Inc.
Director
Ori Biotech
Director

Director Compensation

FY 2025
Fees earned or paid in cash
$48,333
ComponentBoard and committee cash retainers earned in FY2025
Stock awards
$101,257
ComponentAnnual RSU grant, ASC 718 grant-date fair value
Option awards
$33,753
ComponentAnnual NQSO grant, ASC 718 grant-date fair value
Total
$183,343

Also at 908 Devices Inc.

Related

See how VectorShift works for your firm

Request Demo